195 results
8-K
EX-99.1
ANIX
Anixa Biosciences Inc
8 May 24
Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines
8:35am
: Statements that are not historical fact may be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act
S-8
ANIX
Anixa Biosciences Inc
16 Jan 24
Registration of securities for employees
4:43pm
, including revenue from the settlement of litigation (during the year ended October 31, 2023, we derived approximately $210,000 of revenue from … our ability to develop and commercialize products and technology covered by these license agreements and we may be subjected to future litigation
8-K
EX-99.1
g3vhmt
7 Dec 23
Regulation FD Disclosure
6:01am
8-K
28qsnf
7 Dec 23
Regulation FD Disclosure
6:01am
8-K
sekt 7g8i6x67my2nhxj
17 Apr 23
Anixa Biosciences and Cleveland Clinic Present Positive Data for Phase 1 Study of Breast Cancer Vaccine
1:45pm
8-K
EX-99.1
hxl67b4jy2c
17 Apr 23
Anixa Biosciences and Cleveland Clinic Present Positive Data for Phase 1 Study of Breast Cancer Vaccine
1:45pm
8-K
y1y3wc7sj2ou1g3udt6
8 Dec 22
Regulation FD Disclosure
8:40am
8-K
p8cato51h79 wj
29 Sep 22
Regulation FD Disclosure
8:30am
S-8
jv7v34she5o
4 Jan 22
Registration of securities for employees
4:12pm